Repurposing of antibiotics for clinical management of COVID-19: a narrative review

A Yacouba, A Olowo-Okere, I Yunusa - Annals of Clinical Microbiology …, 2021 - Springer
Background Drug repurposing otherwise known as drug repositioning or drug re-profiling is
a time-tested approach in drug discovery through which new medical uses are being …

Visualization of zika virus infection via a light-initiated bio-orthogonal cycloaddition labeling strategy

J Zheng, R Yue, R Yang, Q Wu, Y Wu… - … in Bioengineering and …, 2022 - frontiersin.org
Zika virus (ZIKV) is a re-emerging flavivirus that leads to devastating consequences for fetal
development. It is crucial to visualize the pathogenicity activities of ZIKV ranging from …

Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2

M Malani, P Salunke, S Kulkarni, GK Jain… - Journal of …, 2022 - Taylor & Francis
The limited time indorsed to face the COVID-19 emergency and large number of deaths
across the globe, poses an unrelenting challenge to find apt therapeutic approaches …

Structural dynamics of chlorpromazine (CPZ) drug with dipalmitoylphosphatidylcholine (DPPC) lipid: a potential drug for SARS-CoV-2

S Mishra, AK Mishra, R Sharma - Journal of Biomolecular Structure …, 2023 - Taylor & Francis
There is an urgent requirement for drug discovery and more importantly drug repositioning
due to infectious new Severe Acute Respiratory Syndrome coronavirus 2. As per the recent …

Covid-19 farmakoterapisi

BY Dikmen, Y Pat, E Dilekoz, GY Summak… - Veteriner Farmakoloji …, 2020 - dergipark.org.tr
The novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been described as a global pandemic. Regardless the …

Psychotropics and COVID-19: an analysis of safety and prophylaxis

H Javelot, C Straczek, G Meyer, CGF Faria, L Weiner… - L'encephale, 2021 - Elsevier
The use of psychotropics during the COVID-19 pandemic has raised two questions, in order
of importance: first, what changes should be made to pharmacological treatments prescribed …

Molecular insights of SARS-CoV-2 infection and molecular treatments

L Abdurrahman, X Fang, Y Zhang - Current Molecular …, 2022 - ingentaconnect.com
The coronavirus disease emerged in December 2019 (COVID-19) is caused by Severe
Acute Respiratory Syndrome-related coronavirus 2 (SARS-CoV-2). Its rapid global spread …

[PDF][PDF] Cotrimoxazole and teicoplanin in the management of Covid-19: Pleiotropic effects, shadows and lights

HM Al-Kuraishy, AI Al-Gareeb… - Current Medical and …, 2020 - academia.edu
At present, coronavirus disease 2019 (Covid-19), caused by SARS-CoV-2 infection, has
turned into a global pandemic. Comparable to the H7N9 virus, SARS-CoV-2 causes soaring …

Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19

E Shirbhate, P Patel, VK Patel… - Mini Reviews in …, 2021 - ingentaconnect.com
The novel coronavirus disease-19 (COVID-19) is a global pandemic that emerged from
Wuhan, China, and has spread all around the world, affecting 216 countries or territories …

Avaliação dos principais fármacos utilizados para o sars-cov-2: uma prospecção cientifica e tecnológica

KMR da Silva, PB da Silva, HJN da Silva… - Research, Society and …, 2021 - rsdjournal.org
Coronaviruses are viruses that cause respiratory infections that can affect animals and
humans. The SARS-CoV-2 epidemic, which caused COVID-19, began in Wuhan (China) in …